APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Hepatitis B Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Hepatitis B Immunoglobulin Market Analysis and Forecast 2026-2032

Report ID 173999790222 December 2025196 pages

Choose your research edition.

Industry ResearchHuman Hepatitis B Immunoglobulin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Hepatitis B Immunoglobulin Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Hepatitis B Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Hepatitis B Immunoglobulin Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Hepatitis B Immunoglobulin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Hepatitis B Immunoglobulin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Hepatitis B Immunoglobulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Hepatitis B Immunoglobulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Hepatitis B Immunoglobulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Hepatitis B Immunoglobulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Hepatitis B Immunoglobulin include Shanghai Institute of Biological, China Biologic, Sichuan Yuanda Shuyang, Shanghai RAAS, Shuanglin Bio-pharmacy, Boya Bio-pharmaceutical, Hualan Biological, Tiantan Biologic and Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Hepatitis B Immunoglobulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Hepatitis B Immunoglobulin, also provides the sales of main regions and countries. Of the upcoming market potential for Human Hepatitis B Immunoglobulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Hepatitis B Immunoglobulin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Hepatitis B Immunoglobulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Hepatitis B Immunoglobulin sales, projected growth trends, production technology, application and end-user industry.

Human Hepatitis B Immunoglobulin Segment by Company

Shanghai Institute of Biological

China Biologic

Sichuan Yuanda Shuyang

Shanghai RAAS

Shuanglin Bio-pharmacy

Boya Bio-pharmaceutical

Hualan Biological

Tiantan Biologic

Bayer

Baxter

Octapharma

Grifols

CSL

Human Hepatitis B Immunoglobulin Segment by Type

400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)

Human Hepatitis B Immunoglobulin Segment by Application

Hepatitis B Carrier

Hepatitis B Close Contacts

Human Hepatitis B Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Hepatitis B Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Hepatitis B Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Hepatitis B Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Hepatitis B Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Hepatitis B Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Hepatitis B Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Major Manufacturers Table 3. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Major Manufacturers Table 4. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Major Manufacturers Table 5. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hepatitis B Carrier Major Manufacturers Table 7. Hepatitis B Close Contacts Major Manufacturers Table 8. Human Hepatitis B Immunoglobulin Industry Trends Table 9. Human Hepatitis B Immunoglobulin Industry Drivers Table 10. Human Hepatitis B Immunoglobulin Industry Opportunities and Challenges Table 11. Human Hepatitis B Immunoglobulin Industry Restraints Table 12. Global Human Hepatitis B Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Human Hepatitis B Immunoglobulin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2021-2026) Table 16. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2027-2032) Table 17. Global Human Hepatitis B Immunoglobulin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2026) & (k units) Table 19. Global Human Hepatitis B Immunoglobulin Sales by Region (2027-2032) & (k units) Table 20. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2021-2026) Table 21. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2027-2032) Table 22. Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Human Hepatitis B Immunoglobulin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Human Hepatitis B Immunoglobulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Human Hepatitis B Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Human Hepatitis B Immunoglobulin Manufacturers, Product Type & Application Table 30. Global Human Hepatitis B Immunoglobulin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Human Hepatitis B Immunoglobulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Human Hepatitis B Immunoglobulin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2026) Table 37. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2027-2032) Table 38. Global Human Hepatitis B Immunoglobulin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 40. Global Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 41. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2026) Table 42. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2027-2032) Table 43. Global Human Hepatitis B Immunoglobulin Price by Type (2021-2026) & (US$/unit) Table 44. Global Human Hepatitis B Immunoglobulin Price by Type (2027-2032) & (US$/unit) Table 45. Global Human Hepatitis B Immunoglobulin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2026) Table 49. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2027-2032) Table 50. Global Human Hepatitis B Immunoglobulin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 52. Global Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 53. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2026) Table 54. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2027-2032) Table 55. Global Human Hepatitis B Immunoglobulin Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Hepatitis B Immunoglobulin Price by Application (2027-2032) & (US$/unit) Table 57. Shanghai Institute of Biological Company Information Table 58. Shanghai Institute of Biological Business Overview Table 59. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolio Table 61. Shanghai Institute of Biological Recent Development Table 62. China Biologic Company Information Table 63. China Biologic Business Overview Table 64. China Biologic Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. China Biologic Human Hepatitis B Immunoglobulin Product Portfolio Table 66. China Biologic Recent Development Table 67. Sichuan Yuanda Shuyang Company Information Table 68. Sichuan Yuanda Shuyang Business Overview Table 69. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolio Table 71. Sichuan Yuanda Shuyang Recent Development Table 72. Shanghai RAAS Company Information Table 73. Shanghai RAAS Business Overview Table 74. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolio Table 76. Shanghai RAAS Recent Development Table 77. Shuanglin Bio-pharmacy Company Information Table 78. Shuanglin Bio-pharmacy Business Overview Table 79. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolio Table 81. Shuanglin Bio-pharmacy Recent Development Table 82. Boya Bio-pharmaceutical Company Information Table 83. Boya Bio-pharmaceutical Business Overview Table 84. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolio Table 86. Boya Bio-pharmaceutical Recent Development Table 87. Hualan Biological Company Information Table 88. Hualan Biological Business Overview Table 89. Hualan Biological Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolio Table 91. Hualan Biological Recent Development Table 92. Tiantan Biologic Company Information Table 93. Tiantan Biologic Business Overview Table 94. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolio Table 96. Tiantan Biologic Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bayer Human Hepatitis B Immunoglobulin Product Portfolio Table 101. Bayer Recent Development Table 102. Baxter Company Information Table 103. Baxter Business Overview Table 104. Baxter Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Baxter Human Hepatitis B Immunoglobulin Product Portfolio Table 106. Baxter Recent Development Table 107. Octapharma Company Information Table 108. Octapharma Business Overview Table 109. Octapharma Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Octapharma Human Hepatitis B Immunoglobulin Product Portfolio Table 111. Octapharma Recent Development Table 112. Grifols Company Information Table 113. Grifols Business Overview Table 114. Grifols Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Grifols Human Hepatitis B Immunoglobulin Product Portfolio Table 116. Grifols Recent Development Table 117. CSL Company Information Table 118. CSL Business Overview Table 119. CSL Human Hepatitis B Immunoglobulin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. CSL Human Hepatitis B Immunoglobulin Product Portfolio Table 121. CSL Recent Development Table 122. North America Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 125. North America Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 126. North America Human Hepatitis B Immunoglobulin Sales Price by Type (2021-2026) & (US$/unit) Table 127. North America Human Hepatitis B Immunoglobulin Sales Price by Type (2027-2032) & (US$/unit) Table 128. North America Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 131. North America Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 132. North America Human Hepatitis B Immunoglobulin Sales Price by Application (2021-2026) & (US$/unit) Table 133. North America Human Hepatitis B Immunoglobulin Sales Price by Application (2027-2032) & (US$/unit) Table 134. North America Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 138. North America Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 139. North America Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 140. North America Human Hepatitis B Immunoglobulin Sales Price by Country (2021-2026) & (US$/unit) Table 141. North America Human Hepatitis B Immunoglobulin Sales Price by Country (2027-2032) & (US$/unit) Table 142. United States Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 143. Canada Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 144. Mexico Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 145. Europe Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 148. Europe Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 149. Europe Human Hepatitis B Immunoglobulin Sales Price by Type (2021-2026) & (US$/unit) Table 150. Europe Human Hepatitis B Immunoglobulin Sales Price by Type (2027-2032) & (US$/unit) Table 151. Europe Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 154. Europe Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 155. Europe Human Hepatitis B Immunoglobulin Sales Price by Application (2021-2026) & (US$/unit) Table 156. Europe Human Hepatitis B Immunoglobulin Sales Price by Application (2027-2032) & (US$/unit) Table 157. Europe Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 161. Europe Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 162. Europe Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 163. Europe Human Hepatitis B Immunoglobulin Sales Price by Country (2021-2026) & (US$/unit) Table 164. Europe Human Hepatitis B Immunoglobulin Sales Price by Country (2027-2032) & (US$/unit) Table 165. Germany Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 166. France Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 167. U.K. Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 168. Italy Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 169. Russia Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 170. Spain Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 173. Sweden Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 174. Poland Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 175. China Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 176. China Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 177. China Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 178. China Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 179. China Human Hepatitis B Immunoglobulin Sales Price by Type (2021-2026) & (US$/unit) Table 180. China Human Hepatitis B Immunoglobulin Sales Price by Type (2027-2032) & (US$/unit) Table 181. China Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 182. China Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 183. China Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 184. China Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 185. China Human Hepatitis B Immunoglobulin Sales Price by Application (2021-2026) & (US$/unit) Table 186. China Human Hepatitis B Immunoglobulin Sales Price by Application (2027-2032) & (US$/unit) Table 187. Asia Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 190. Asia Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 191. Asia Human Hepatitis B Immunoglobulin Sales Price by Type (2021-2026) & (US$/unit) Table 192. Asia Human Hepatitis B Immunoglobulin Sales Price by Type (2027-2032) & (US$/unit) Table 193. Asia Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 196. Asia Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 197. Asia Human Hepatitis B Immunoglobulin Sales Price by Application (2021-2026) & (US$/unit) Table 198. Asia Human Hepatitis B Immunoglobulin Sales Price by Application (2027-2032) & (US$/unit) Table 199. Asia Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 203. Asia Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 204. Asia Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 205. Asia Human Hepatitis B Immunoglobulin Sales Price by Country (2021-2026) & (US$/unit) Table 206. Asia Human Hepatitis B Immunoglobulin Sales Price by Country (2027-2032) & (US$/unit) Table 207. Japan Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 208. South Korea Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 209. India Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 210. Australia Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Human Hepatitis B Immunoglobulin Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Human Hepatitis B Immunoglobulin Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Human Hepatitis B Immunoglobulin Sales by Type (2021-2026) & (k units) Table 216. SAMEA Human Hepatitis B Immunoglobulin Sales by Type (2027-2032) & (k units) Table 217. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Type (2021-2026) & (US$/unit) Table 218. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Type (2027-2032) & (US$/unit) Table 219. SAMEA Human Hepatitis B Immunoglobulin Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Human Hepatitis B Immunoglobulin Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Human Hepatitis B Immunoglobulin Sales by Application (2021-2026) & (k units) Table 222. SAMEA Human Hepatitis B Immunoglobulin Sales by Application (2027-2032) & (k units) Table 223. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Application (2021-2026) & (US$/unit) Table 224. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Application (2027-2032) & (US$/unit) Table 225. SAMEA Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 229. SAMEA Human Hepatitis B Immunoglobulin Sales by Country (2021-2026) & (k units) Table 230. SAMEA Human Hepatitis B Immunoglobulin Sales by Country (2027-2032) & (k units) Table 231. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Country (2021-2026) & (US$/unit) Table 232. SAMEA Human Hepatitis B Immunoglobulin Sales Price by Country (2027-2032) & (US$/unit) Table 233. Brazil Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 234. Argentina Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 235. Chile Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 236. Colombia Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 237. Peru Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 239. Israel Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 240. UAE Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 241. Turkey Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 242. Iran Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 243. Egypt Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Human Hepatitis B Immunoglobulin Distributors List Table 247. Human Hepatitis B Immunoglobulin Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Human Hepatitis B Immunoglobulin Image Figure 2. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Hepatitis B Immunoglobulin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 5. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 6. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Image Figure 7. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Human Hepatitis B Immunoglobulin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hepatitis B Carrier Image Figure 10. Hepatitis B Close Contacts Image Figure 11. Global Human Hepatitis B Immunoglobulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Human Hepatitis B Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 13. Global Human Hepatitis B Immunoglobulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2021-2032) Figure 16. Global Human Hepatitis B Immunoglobulin Sales (2021-2032) & (k units) Figure 17. Global Human Hepatitis B Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Human Hepatitis B Immunoglobulin Sales YoY (2021-2032) & (k units) Figure 20. Europe Human Hepatitis B Immunoglobulin Sales YoY (2021-2032) & (k units) Figure 21. China Human Hepatitis B Immunoglobulin Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Human Hepatitis B Immunoglobulin Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Human Hepatitis B Immunoglobulin Sales YoY (2021-2032) & (k units) Figure 24. Global Human Hepatitis B Immunoglobulin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Human Hepatitis B Immunoglobulin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Human Hepatitis B Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2032) Figure 30. Global Human Hepatitis B Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2032) Figure 33. Global Human Hepatitis B Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2032) Figure 36. Global Human Hepatitis B Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2032) Figure 39. North America Human Hepatitis B Immunoglobulin Revenue Share by Type (2021-2032) Figure 40. North America Human Hepatitis B Immunoglobulin Sales Share by Type (2021-2032) Figure 41. North America Human Hepatitis B Immunoglobulin Revenue Share by Application (2021-2032) Figure 42. North America Human Hepatitis B Immunoglobulin Sales Share by Application (2021-2032) Figure 43. North America Human Hepatitis B Immunoglobulin Revenue Share by Country (2021-2032) Figure 44. North America Human Hepatitis B Immunoglobulin Sales Share by Country (2021-2032) Figure 45. Europe Human Hepatitis B Immunoglobulin Revenue Share by Type (2021-2032) Figure 46. Europe Human Hepatitis B Immunoglobulin Sales Share by Type (2021-2032) Figure 47. Europe Human Hepatitis B Immunoglobulin Revenue Share by Application (2021-2032) Figure 48. Europe Human Hepatitis B Immunoglobulin Sales Share by Application (2021-2032) Figure 49. Europe Human Hepatitis B Immunoglobulin Revenue Share by Country (2021-2032) Figure 50. Europe Human Hepatitis B Immunoglobulin Sales Share by Country (2021-2032) Figure 51. China Human Hepatitis B Immunoglobulin Revenue Share by Type (2021-2032) Figure 52. China Human Hepatitis B Immunoglobulin Sales Share by Type (2021-2032) Figure 53. China Human Hepatitis B Immunoglobulin Revenue Share by Application (2021-2032) Figure 54. China Human Hepatitis B Immunoglobulin Sales Share by Application (2021-2032) Figure 55. Asia Human Hepatitis B Immunoglobulin Revenue Share by Type (2021-2032) Figure 56. Asia Human Hepatitis B Immunoglobulin Sales Share by Type (2021-2032) Figure 57. Asia Human Hepatitis B Immunoglobulin Revenue Share by Application (2021-2032) Figure 58. Asia Human Hepatitis B Immunoglobulin Sales Share by Application (2021-2032) Figure 59. Asia Human Hepatitis B Immunoglobulin Revenue Share by Country (2021-2032) Figure 60. Asia Human Hepatitis B Immunoglobulin Sales Share by Country (2021-2032) Figure 61. SAMEA Human Hepatitis B Immunoglobulin Revenue Share by Type (2021-2032) Figure 62. SAMEA Human Hepatitis B Immunoglobulin Sales Share by Type (2021-2032) Figure 63. SAMEA Human Hepatitis B Immunoglobulin Revenue Share by Application (2021-2032) Figure 64. SAMEA Human Hepatitis B Immunoglobulin Sales Share by Application (2021-2032) Figure 65. SAMEA Human Hepatitis B Immunoglobulin Revenue Share by Country (2021-2032) Figure 66. SAMEA Human Hepatitis B Immunoglobulin Sales Share by Country (2021-2032) Figure 67. Human Hepatitis B Immunoglobulin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Hepatitis B Immunoglobulin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  • 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  • 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
Applications
  • Hepatitis B Carrier
  • Hepatitis B Close Contacts
Companies covered
  • Shanghai Institute of Biological
  • China Biologic
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Shuanglin Bio-pharmacy
  • Boya Bio-pharmaceutical
  • Hualan Biological
  • Tiantan Biologic
  • Bayer
  • Baxter
  • Octapharma
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Hepatitis B Immunoglobulin Market by Type
  3. 1.2.1 Global Human Hepatitis B Immunoglobulin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  5. 1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  6. 1.2.4 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG)
  7. 1.3 Human Hepatitis B Immunoglobulin Market by Application
  8. 1.3.1 Global Human Hepatitis B Immunoglobulin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hepatitis B Carrier
  10. 1.3.3 Hepatitis B Close Contacts
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Human Hepatitis B Immunoglobulin Market Dynamics
  1. 2.1 Human Hepatitis B Immunoglobulin Industry Trends
  2. 2.2 Human Hepatitis B Immunoglobulin Industry Drivers
  3. 2.3 Human Hepatitis B Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Human Hepatitis B Immunoglobulin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Hepatitis B Immunoglobulin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Hepatitis B Immunoglobulin Revenue by Region
  3. 3.2.1 Global Human Hepatitis B Immunoglobulin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Hepatitis B Immunoglobulin Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Hepatitis B Immunoglobulin Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Hepatitis B Immunoglobulin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Hepatitis B Immunoglobulin Sales by Region
  9. 3.4.1 Global Human Hepatitis B Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Hepatitis B Immunoglobulin Sales by Region (2021-2026)
  11. 3.4.3 Global Human Hepatitis B Immunoglobulin Sales by Region (2027-2032)
  12. 3.4.4 Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers
  2. 4.1.1 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Hepatitis B Immunoglobulin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Hepatitis B Immunoglobulin Sales by Manufacturers
  6. 4.2.1 Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Hepatitis B Immunoglobulin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Hepatitis B Immunoglobulin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Hepatitis B Immunoglobulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Hepatitis B Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Hepatitis B Immunoglobulin Manufacturers, Product Type & Application
  13. 4.7 Global Human Hepatitis B Immunoglobulin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Hepatitis B Immunoglobulin Market CR5 and HHI
  16. 4.8.2 2025 Human Hepatitis B Immunoglobulin Tier 1, Tier 2, and Tier 3
5 Human Hepatitis B Immunoglobulin Market by Type
  1. 5.1 Global Human Hepatitis B Immunoglobulin Revenue by Type
  2. 5.1.1 Global Human Hepatitis B Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Hepatitis B Immunoglobulin Sales by Type
  6. 5.2.1 Global Human Hepatitis B Immunoglobulin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Hepatitis B Immunoglobulin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Hepatitis B Immunoglobulin Price by Type
6 Human Hepatitis B Immunoglobulin Market by Application
  1. 6.1 Global Human Hepatitis B Immunoglobulin Revenue by Application
  2. 6.1.1 Global Human Hepatitis B Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Hepatitis B Immunoglobulin Sales by Application
  6. 6.2.1 Global Human Hepatitis B Immunoglobulin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Hepatitis B Immunoglobulin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Hepatitis B Immunoglobulin Price by Application
7 Company Profiles
  1. 7.1 Shanghai Institute of Biological
  2. 7.1.1 Shanghai Institute of Biological Company Information
  3. 7.1.2 Shanghai Institute of Biological Business Overview
  4. 7.1.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Portfolio
  6. 7.1.5 Shanghai Institute of Biological Recent Developments
  7. 7.2 China Biologic
  8. 7.2.1 China Biologic Company Information
  9. 7.2.2 China Biologic Business Overview
  10. 7.2.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 China Biologic Human Hepatitis B Immunoglobulin Product Portfolio
  12. 7.2.5 China Biologic Recent Developments
  13. 7.3 Sichuan Yuanda Shuyang
  14. 7.3.1 Sichuan Yuanda Shuyang Company Information
  15. 7.3.2 Sichuan Yuanda Shuyang Business Overview
  16. 7.3.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Portfolio
  18. 7.3.5 Sichuan Yuanda Shuyang Recent Developments
  19. 7.4 Shanghai RAAS
  20. 7.4.1 Shanghai RAAS Company Information
  21. 7.4.2 Shanghai RAAS Business Overview
  22. 7.4.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Product Portfolio
  24. 7.4.5 Shanghai RAAS Recent Developments
  25. 7.5 Shuanglin Bio-pharmacy
  26. 7.5.1 Shuanglin Bio-pharmacy Company Information
  27. 7.5.2 Shuanglin Bio-pharmacy Business Overview
  28. 7.5.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Portfolio
  30. 7.5.5 Shuanglin Bio-pharmacy Recent Developments
  31. 7.6 Boya Bio-pharmaceutical
  32. 7.6.1 Boya Bio-pharmaceutical Company Information
  33. 7.6.2 Boya Bio-pharmaceutical Business Overview
  34. 7.6.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Portfolio
  36. 7.6.5 Boya Bio-pharmaceutical Recent Developments
  37. 7.7 Hualan Biological
  38. 7.7.1 Hualan Biological Company Information
  39. 7.7.2 Hualan Biological Business Overview
  40. 7.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Product Portfolio
  42. 7.7.5 Hualan Biological Recent Developments
  43. 7.8 Tiantan Biologic
  44. 7.8.1 Tiantan Biologic Company Information
  45. 7.8.2 Tiantan Biologic Business Overview
  46. 7.8.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Product Portfolio
  48. 7.8.5 Tiantan Biologic Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bayer Human Hepatitis B Immunoglobulin Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 Baxter
  56. 7.10.1 Baxter Company Information
  57. 7.10.2 Baxter Business Overview
  58. 7.10.3 Baxter Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Baxter Human Hepatitis B Immunoglobulin Product Portfolio
  60. 7.10.5 Baxter Recent Developments
  61. 7.11 Octapharma
  62. 7.11.1 Octapharma Company Information
  63. 7.11.2 Octapharma Business Overview
  64. 7.11.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Octapharma Human Hepatitis B Immunoglobulin Product Portfolio
  66. 7.11.5 Octapharma Recent Developments
  67. 7.12 Grifols
  68. 7.12.1 Grifols Company Information
  69. 7.12.2 Grifols Business Overview
  70. 7.12.3 Grifols Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Grifols Human Hepatitis B Immunoglobulin Product Portfolio
  72. 7.12.5 Grifols Recent Developments
  73. 7.13 CSL
  74. 7.13.1 CSL Company Information
  75. 7.13.2 CSL Business Overview
  76. 7.13.3 CSL Human Hepatitis B Immunoglobulin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CSL Human Hepatitis B Immunoglobulin Product Portfolio
  78. 7.13.5 CSL Recent Developments
8 North America
  1. 8.1 North America Human Hepatitis B Immunoglobulin Market Size by Type
  2. 8.1.1 North America Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  4. 8.1.3 North America Human Hepatitis B Immunoglobulin Price by Type (2021-2032)
  5. 8.2 North America Human Hepatitis B Immunoglobulin Market Size by Application
  6. 8.2.1 North America Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  8. 8.2.3 North America Human Hepatitis B Immunoglobulin Price by Application (2021-2032)
  9. 8.3 North America Human Hepatitis B Immunoglobulin Market Size by Country
  10. 8.3.1 North America Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Hepatitis B Immunoglobulin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Hepatitis B Immunoglobulin Market Size by Type
  2. 9.1.1 Europe Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Hepatitis B Immunoglobulin Price by Type (2021-2032)
  5. 9.2 Europe Human Hepatitis B Immunoglobulin Market Size by Application
  6. 9.2.1 Europe Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Hepatitis B Immunoglobulin Price by Application (2021-2032)
  9. 9.3 Europe Human Hepatitis B Immunoglobulin Market Size by Country
  10. 9.3.1 Europe Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Hepatitis B Immunoglobulin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Hepatitis B Immunoglobulin Market Size by Type
  2. 10.1.1 China Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  3. 10.1.2 China Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  4. 10.1.3 China Human Hepatitis B Immunoglobulin Price by Type (2021-2032)
  5. 10.2 China Human Hepatitis B Immunoglobulin Market Size by Application
  6. 10.2.1 China Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  7. 10.2.2 China Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  8. 10.2.3 China Human Hepatitis B Immunoglobulin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Hepatitis B Immunoglobulin Market Size by Type
  2. 11.1.1 Asia Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Hepatitis B Immunoglobulin Price by Type (2021-2032)
  5. 11.2 Asia Human Hepatitis B Immunoglobulin Market Size by Application
  6. 11.2.1 Asia Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Hepatitis B Immunoglobulin Price by Application (2021-2032)
  9. 11.3 Asia Human Hepatitis B Immunoglobulin Market Size by Country
  10. 11.3.1 Asia Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Hepatitis B Immunoglobulin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Hepatitis B Immunoglobulin Market Size by Type
  2. 12.1.1 SAMEA Human Hepatitis B Immunoglobulin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Hepatitis B Immunoglobulin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Hepatitis B Immunoglobulin Price by Type (2021-2032)
  5. 12.2 SAMEA Human Hepatitis B Immunoglobulin Market Size by Application
  6. 12.2.1 SAMEA Human Hepatitis B Immunoglobulin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Hepatitis B Immunoglobulin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Hepatitis B Immunoglobulin Price by Application (2021-2032)
  9. 12.3 SAMEA Human Hepatitis B Immunoglobulin Market Size by Country
  10. 12.3.1 SAMEA Human Hepatitis B Immunoglobulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Hepatitis B Immunoglobulin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Hepatitis B Immunoglobulin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Hepatitis B Immunoglobulin Value Chain Analysis
  2. 13.1.1 Human Hepatitis B Immunoglobulin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Hepatitis B Immunoglobulin Production Mode & Process
  6. 13.2 Human Hepatitis B Immunoglobulin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Hepatitis B Immunoglobulin Distributors
  9. 13.2.3 Human Hepatitis B Immunoglobulin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst